ClinicalTrials+1 Classified as prohibited by anti-doping authorities (USADA/WADA) and noted by other regulators (e.g., TGA) as an unapproved growth-factor peptide
Maquart FX, Simon A, Pasco S, Monboisse JC
QCT inhibits ferroptosis, inflammation, and endothelial dysfunction in vitro To investigate whether QCT, a small-molecular drug with both anti-inflammatory and anti-ferroptosis properties, can protect against Erastin-induced ferroptosis and associated disruptions in cell viability
If the goal is weight management without diabetes, only Wegovy, Zepbound, and Saxenda are approved for that use
Register Now The virtual event is free and open to all healthcare practitioners, however, pre-registration is required